Abstract

QT interval prolongation is a predictor of the life-threatening cardiac arrhythmias — polymorphic ventricular tachycardia (torsade de pointes). Long QT syndrome may be congenital or acquired. It is known that a wide range of both antiarrhythmic and non-cardiac medications might lead to QT interval prolongation. List of drugs that cause QT prolongation is constantly growing and being updated. The review contains current data on the clinical significance of the control of QT interval duration within drug therapy. Clinical conditions associated with an increased risk of QT interval prolongation are described. Drugs that can induce QT prolongation are also discussed.

Highlights

  • The QT long syndrome: clinical and diagnostic aspects QT interval prolongation is a predictor of the life-threatening cardiac arrhythmias – polymorphic ventricular tachycardia

  • It is known that a wide range of both antiarrhythmic and non-cardiac medications might lead to QT interval prolongation

  • Clinical conditions associated with an increased risk of QT interval prolongation are described

Read more

Summary

Introduction

Durata intervalului QT poate crește prin utilizarea unui șir de preparate medicamentoase. The QT long syndrome: clinical and diagnostic aspects QT interval prolongation is a predictor of the life-threatening cardiac arrhythmias – polymorphic ventricular tachycardia (torsade de pointes).

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.